New diabetes drug ZT002 passes first safety check in healthy volunteers
Disease control
Completed
This early-stage study tested a new drug called ZT002 in 32 healthy adults to see if it is safe and how the body processes it. The goal is to develop a treatment for type 2 diabetes. Participants received either the drug or a placebo, and researchers monitored for side effects. T…
Phase: PHASE1 • Sponsor: QL Biopharmaceutical Australia Pty Ltd • Aim: Disease control
Last updated May 16, 2026 10:19 UTC